Melanie Wosnitza

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

Dinesh Khanna, Yannick Allanore, Christopher P. Denton et al. · Annals of the Rheumatic Diseases · 2020 · 104 citations · Full text

Plasticity of human adipose stem cells to perform adipogenic and endothelial differentiation

Melanie Wosnitza, Karsten Hemmrich, Andreas Gröger et al. · Differentiation · 2006 · 102 citations

Tissue Engineering, Regenerative Medicine, Induced Pluripotent Stem Cell +10

Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial

Paulus Kirchhof, Michael D. Ezekowitz, Yanish Purmah et al. · TH Open · 2020 · 53 citations · Full text

Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study

Peter V. Dicpinigaitis, Alyn H. Morice, John A. Smith et al. · Lung · 2023 · 34 citations · Full text

Paganini Study, Pharmacology, Placebo-controlled Phase 2B +5

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial

Oliver Distler, Yannick Allanore, Christopher P. Denton et al. · The Lancet Rheumatology · 2023 · 12 citations

Rheumatology, Systemic Scleroderma, Phase 2B +8